Cordlife Group Limited
Annual Report 2016
119
Notes to
The Financial Statements
for the financial year ended 30 June 2016
40. Segment reporting (cont’d)
Segment assets and liabilities
Banking
Diagnostics
Others
*
Total
$’000
$’000
$’000
$’000
Year ended 30 June 2016
Additions to non-current assets, comprising
additions to property, plant and equipment
and intangible assets
5,412
–
–
5,412
Segment assets
284,162
306
946
285,414
Available-for-sale asset
4,200
Bond receivable and interest receivable on
bond receivable (Note 19)
4,343
Investment properties
9,152
Deferred tax asset
220
Eliminations
+
(32,759)
Per consolidated financial statements
270,570
Segment liabilities
86,568
504
11,370
98,442
Notes payable
67,403
Tax payables
592
Deferred tax liabilities
4,073
Eliminations
+
(32,695)
Per consolidated financial statements
137,815
Year ended 30 June 2015
Additions to non-current assets, comprising
additions to property, plant and equipment
and intangible assets
2,789
4
–
2,793
Investment in associate
13,543
–
–
13,543
Segment assets
168,034
251
1,115
169,400
Financial asset designated at fair value
through profit or loss
60,858
Derivative asset
37,971
Loan to and interest receivable from
external party (Note 19)
62,554
Bond receivable and interest receivable on
bond receivable (Note 19)
38,213
Investment properties
3,795
Eliminations
+
(39,828)
Per consolidated financial statements
332,963
Segment liabilities
84,984
266
6,884
92,134
Notes payable
117,463
Tax payables
1,103
Deferred tax liabilities
91
Eliminations
+
(39,774)
Per consolidated financial statements
171,017
+
Inter-segment balances are eliminated on consolidation.
*
Others refer to the assets and liabilities of subsidiaries not in the principal activities of the provision of cord blood and
cord lining banking and diagnostic services.
